
Biosimilars may need more time to devleop in the market.

Biosimilars may need more time to devleop in the market.

Results from new ASHP Survey.

Type 2 diabetes mellitus is a risk factor for incident heart failure, according to a new scientific statement from the American Heart Association (AHA), and it increases the risk of morbidity and mortality in patients with established disease.

Published: June 14th 2019 | Updated:

Published: July 10th 2019 | Updated:

Published: October 1st 2019 | Updated: